These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 677861)

  • 41. In vitro action of carbenicillin against bacteria isolated from clinical material.
    Isenberg HD; Siegel M
    Appl Microbiol; 1969 Sep; 18(3):387-92. PubMed ID: 4392088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.
    Daschner F; Langmaack H; Grehn M; Steffens A; Just M
    Chemotherapy; 1981; 27(1):39-43. PubMed ID: 6452252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro studies of a new semisynthetic penicillin, 6-(d-alpha-sulfoaminophenylacetamido)-penicillanic acid.
    Bodey GP; Stewart D
    Appl Microbiol; 1969 Jul; 18(1):76-9. PubMed ID: 4896105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azlocillin: a new broad spectrum penicillin.
    Sanders CC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():21-31. PubMed ID: 6619029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.
    Dhawan V; Marso E; Martin WJ; Young LS
    Antimicrob Agents Chemother; 1977 Jan; 11(1):64-73. PubMed ID: 836015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.
    Bodey GP; Stewart D
    Appl Microbiol; 1971 Apr; 21(4):710-7. PubMed ID: 4930281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin.
    Machka K; Baierl W; Braveny I
    Eur J Clin Microbiol; 1982 Aug; 1(4):238-42. PubMed ID: 6217066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
    Thabaut A; Durosoir JL; Saliou P
    Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
    Drusano GL; Schimpff SC; Hewitt WL
    Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1983 Jun; 23(6):902-6. PubMed ID: 6225391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
    Swarifi R; Lee M; Ojeda L; Tabib M
    J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.
    Saino Y; Hattori Y; Koshi T; Kobayashi F; Oda T; Mitsuhashi S
    Antimicrob Agents Chemother; 1984 Aug; 26(2):187-91. PubMed ID: 6548350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):743-9. PubMed ID: 6446879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.
    White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG
    Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
    Hoogkamp-Korstanje JA; Meijer CA
    Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.